The study examined individuals who had exhausted at least three months of conservative care before receiving ultrasound-guided applications of Wharton’s Jelly allografts. Participants received between one and three applications of 150 mg of tissue at sites ranging from C1 to C7. The authors utilized the Numeric Pain Rating Scale and the Western Ontario and McMaster Universities Arthritis Index to quantify patient progress from their initial visits to the study’s conclusion.
Regenative Labs Reports Positive Outcomes in Cervical Spine Study
A 31-patient observational study published in Medical Research Archives reports reduced pain and improved function in individuals treated with cryopreserved umbilical cord tissue allografts. Researchers documented no adverse events throughout the study, which tracked patients suffering from degenerative cervical paraspinal muscle conditions and enthesopathy.
Data indicated statistically significant improvements in pain and function, particularly among the triple-application group, which saw NPRS scores drop from 7.00 to 1.86. The research team, led by Conrad Tamea and Regenative Labs CEO Tyler Barrett, noted that the structural collagen-rich matrix of the umbilical tissue aligns with the fibrocartilage found in cervical entheses. Barrett emphasized that the publication serves as part of the company's broader effort to build an evidence base for birth tissue applications through transparent reporting. This paper marks the 19th peer-reviewed study contributed by the Pensacola-based manufacturer regarding the clinical use of its regenerative products.
Comments (0)
No comments yet. Be the first!